{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:44:56Z","timestamp":1760233496870,"version":"build-2065373602"},"reference-count":73,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:00:00Z","timestamp":1610841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Defence","award":["D85D10000250001"],"award-info":[{"award-number":["D85D10000250001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Military personnel of all armed forces receive multiple vaccinations and have been doing so since long ago, but relatively few studies have investigated the possible negative or positive interference of simultaneous vaccinations. As a contribution to fill this gap, we analyzed the response to the live trivalent measles\/mumps\/rubella (MMR), the inactivated hepatitis A virus (HAV), the inactivated trivalent polio, and the trivalent subunits influenza vaccines in two cohorts of Italian military personnel. The first cohort was represented by 108 students from military schools and the second by 72 soldiers engaged in a nine-month mission abroad. MMR and HAV vaccines had never been administered before, whereas inactivated polio was administered to adults primed at infancy with a live trivalent oral polio vaccine. Accordingly, nearly all subjects had baseline antibodies to polio types 1 and 3, but unexpectedly, anti-measles\/-mumps\/-rubella antibodies were present in 82%, 82%, and 73.5% of subjects, respectively (43% for all of the antigens). Finally, anti-HAV antibodies were detectable in 14% and anti-influenza (H1\/H3\/B) in 18% of the study population. At mine months post-vaccination, 92% of subjects had protective antibody levels for all MMR antigens, 96% for HAV, 69% for the three influenza antigens, and 100% for polio types 1 and 3. An inverse relationship between baseline and post-vaccination antibody levels was noticed with all the vaccines. An excellent vaccine immunogenicity, a calculated long antibody persistence, and apparent lack of vaccine interference were observed.<\/jats:p>","DOI":"10.3390\/biomedicines9010087","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T05:17:34Z","timestamp":1610947054000},"page":"87","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunogenicity of Viral Vaccines in the Italian Military"],"prefix":"10.3390","volume":"9","author":[{"given":"Claudia","family":"Ferlito","sequence":"first","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Biselli","sequence":"additional","affiliation":[{"name":"Ispettorato Generale della Sanit\u00e0 Militare, Stato Maggiore della Difesa, Via S. Stefano Rotondo 4, 00184 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-3121","authenticated-orcid":false,"given":"Vincenzo","family":"Visco","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-3564","authenticated-orcid":false,"given":"Maria Sofia","family":"Cattaruzza","sequence":"additional","affiliation":[{"name":"Dipartimento di Sanit\u00e0 Pubblica e Malattie Infettive, Sapienza Universit\u00e0 di Roma, Piazzale Aldo Moro 5, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Capobianchi","sequence":"additional","affiliation":[{"name":"Laboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00149 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-236X","authenticated-orcid":false,"given":"Concetta","family":"Castilletti","sequence":"additional","affiliation":[{"name":"Laboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00149 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Lapa","sequence":"additional","affiliation":[{"name":"Laboratorio di Virologia, IRCCS, Istituto Nazionale Malattie Infettive \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00149 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Marchi","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Magurano","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Ciccaglione","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Chionne","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Madonna","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Donatelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Calzoletti","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela Ileen","family":"Biondo","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaela","family":"Teloni","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Salerno","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-4641","authenticated-orcid":false,"given":"Andrea","family":"Picchianti-Diamanti","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Salemi","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Caporuscio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Autore","sequence":"additional","affiliation":[{"name":"Centro Sperimentale di Volo, Comando Logistico, Aeronautica Militare, Aeroporto Pratica di Mare, Via Pratica di Mare 45, 00040 Pomezia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Lulli","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Borelli","sequence":"additional","affiliation":[{"name":"Servizio Sanitario, Reggimento Lancieri di Montebello, Esercito Italiano, Via Flaminia 826, 00191 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lastilla","sequence":"additional","affiliation":[{"name":"Osservatorio Epidemiologico della Difesa, Ispettorato Generale della Sanit\u00e0 Militare, Stato Maggiore della Difesa, Via S. Stefano Rotondo 4, 00184 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Nisini","sequence":"additional","affiliation":[{"name":"Dipartimento di Malattie Infettive, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0669-2629","authenticated-orcid":false,"given":"Raffaele","family":"D\u2019Amelio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Molecolare, Sapienza Universit\u00e0 di Roma, Via di Grottarossa 1035-1039, 00189 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3389\/fimmu.2018.01397","article-title":"The US Military Commitment to Vaccine Development: A Century of Successes and Challenges","volume":"9","author":"Yoon","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3389\/fimmu.2019.02556","article-title":"Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information","volume":"10","author":"Tagliabue","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid0404.980429","article-title":"Can the military contribute to global surveillance and control of infectious diseases?","volume":"4","author":"Heymann","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2014.07.088","article-title":"Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes","volume":"33","author":"Broderick","year":"2015","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1093\/infdis\/174.Supplement_3.S295","article-title":"Future combined vaccines","volume":"174","author":"Grimprel","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1086\/315119","article-title":"Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A\/hepatitis B vaccine","volume":"180","author":"Frey","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00006454-199405000-00004","article-title":"Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age","volume":"13","author":"Gold","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00008480-199902000-00004","article-title":"Pediatric combination vaccines","volume":"11","author":"Choo","year":"1999","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tashani, M., Heron, L., Wong, M., Rashid, H., and Booy, R. (2017). Tetanus-diphtheria-pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): A randomized, controlled trial. J. Travel Med., 24.","DOI":"10.1093\/jtm\/tax006"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0264-410X(00)00436-9","article-title":"Surveillance of infectious diseases in the Italian military as pre-requisite for tailored vaccination programme","volume":"19","author":"Molica","year":"2001","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/S0264-410X(03)00380-3","article-title":"Vaccination programmes in the Italian military","volume":"21","author":"Biselli","year":"2003","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1001\/jama.284.16.2053","article-title":"Measles-mumps-rubella vaccine in the Italian armed forces","volume":"284","author":"Biselli","year":"2000","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jama.287.9.1114","article-title":"Molecular analysis of early postvaccine mumps-like disease in Italian military recruits","volume":"287","author":"Lista","year":"2002","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/infdis\/jiz508","article-title":"Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study","volume":"221","author":"Bianchi","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3201\/eid1107.041157","article-title":"Hepatitis A, Italy","volume":"11","author":"Mele","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","article-title":"Epidemiology and prevention of hepatitis A in travelers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1080\/21645515.2018.1475812","article-title":"Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy","volume":"14","author":"Giammanco","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_20","unstructured":"(2020, October 22). 68th World Health Assembly, 2015, Agenda Item 15.2. Poliomyelitis. World Health Assembly Journal N\u00b0 4. Available online: www.who.int\/gb."},{"key":"ref_21","first-page":"2276","article-title":"Poliovirus Type 3 Is Eradicated","volume":"322","author":"Kuehn","year":"2019","journal-title":"JAMA"},{"key":"ref_22","unstructured":"World Health Organization (2020, October 22). Statement of the Twenty-Third IHR Emergency Committee. Regarding the International Spread of Poliovirus. Geneva. Available online: https:\/\/www.who.int\/news\/item\/22-10-2020-statement-of-the-twenty-sixth-polio-ihr-emergency-committee."},{"key":"ref_23","first-page":"VII","article-title":"Rapporteur\u2019s Challenge","volume":"Volume 360","author":"Neville","year":"2005","journal-title":"Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, Proceedings of the NATO Advanced Research Workshop on Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, St. Petersburg, Russia, 8\u201311 May 2003"},{"key":"ref_24","first-page":"31","article-title":"WHO Surveys of Military Surveillance for Communicable Diseases","volume":"Volume 360","author":"Neville","year":"2005","journal-title":"Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, Proceedings of the NATO Advanced Research Workshop on Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, St. Petersburg, Russia, 8\u201311 May 2003"},{"key":"ref_25","first-page":"68","article-title":"Influenza Surveillance: Civilian-Military Cooperation in the United States and Considerations for Worldwide Improvement","volume":"Volume 360","author":"Neville","year":"2005","journal-title":"Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, Proceedings of the NATO Advanced Research Workshop on Strengthening Influenza Pandemic Preparedness through Civil-Military Cooperation, St. Petersburg, Russia, 8\u201311 May 2003"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clim.2017.06.001","article-title":"Lack of evidence for post-vaccine onset of autoimmune\/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel","volume":"181","author":"Ferlito","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cei.13202","article-title":"Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults","volume":"194","author":"Ferlito","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1016\/j.vaccine.2018.09.041","article-title":"Tetanus-diphtheria vaccination in adults: The long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1\u221701","volume":"36","author":"Ferlito","year":"2018","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","author":"Gans","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","unstructured":"World Health Organization (1995). Manual of Laboratory Methods for Potency Testing of Vaccines Used in the WHO Expanded Programme on Immunization, World Health Organization. WHO Publication no. WHO\/BLG\/95.1."},{"key":"ref_33","unstructured":"World Health Organization (1997). Manual for the Virological Investigation of Polio, World Health Organization. WHO\/EPI\/GEN\/97.01."},{"key":"ref_34","unstructured":"World Health Organization (1993). Guidelines for WHO\/EPI Collaborative Studies on Poliomyelitis. Standard Procedure for Determining Immunity to Poliovirus Using the Microneutralization Test, World Health Organization. WHO\/EPI\/GEN\/93.9."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(19)31279-6","article-title":"The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: A double-blind, single-centre phase 1 study","volume":"394","author":"Bandyopadhyay","year":"2019","journal-title":"Lancet"},{"key":"ref_36","unstructured":"Kendal, A.P., Pereira, M.S., and Skehel, J.J. (1982). Concepts and Procedures for Laboratory-Based Influenza Surveillance."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciw066","article-title":"Durability of vaccine-induced immunity against tetanus and diphtheria toxins: A cross-sectional analysis","volume":"62","author":"Hammarlund","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus, where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","article-title":"The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900\u20132015","volume":"36","author":"Pezzotti","year":"2018","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0950268802007677","article-title":"Epidemiology of measles, mumps and rubella in Italy","volume":"129","author":"Gabutti","year":"2002","journal-title":"Epidemiol. Infect."},{"key":"ref_42","first-page":"902","article-title":"A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity against Mumps in Young Adults","volume":"221","author":"Kaaijk","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Anichini, G., Gandolfo, C., Fabrizi, S., Miceli, G.B., Terrosi, C., Gori Savellini, G., Prathyumnan, S., Orsi, D., Battista, G., and Cusi, M.G. (2020). Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines, 8.","DOI":"10.3390\/vaccines8010066"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.vaccine.2019.02.030","article-title":"Differential durability of immune responses to measles and mumps following MMR vaccination","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/21645515.2018.1564442","article-title":"Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers","volume":"15","author":"Coppeta","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/imcb.12246","article-title":"The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses","volume":"97","author":"Zimmermann","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"ref_47","unstructured":"Epicentro (2020, March 01). Epatite Virale. Epidemiologia dati SEIEVA. Available online: https:\/\/www.epicentro.iss.it\/epatite\/dati-seieva."},{"key":"ref_48","unstructured":"Zuccaro, O., Tosti, M.E., Mele, A., Spada, E., and SEIEVA Collaborative Group (2012). Epidemiology of Acute Viral Hepatitis in Italy: Results of the Surveillance through SEIEVA (Sistema Epidemiologico Integrato dell\u2019Epatite Virale Acuta), Istituto Superiore di Sanit\u00e0. Available online: https:\/\/www.iss.it\/documents\/20126\/1242154\/98.SEIEVA12_4_2012.pdf\/a38f85e1-0574-6009-9e4a-9e91f027374a?t=1576453048281."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bruni, R., Taffon, S., Equestre, M., Chionne, P., Madonna, E., Rizzo, C., Tosti, M.E., Alfonsi, V., Ricotta, L., and De Medici, D. (2016). Key Role of Sequencing to Trace Hepatitis a Viruses Circulating in Italy during a Large Multi-Country European Foodborne Outbreak in 2013. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149642"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.2807\/ese.14.10.19146-en","article-title":"Hepatitis A seroprevalence in Tuscany, Italy","volume":"14","author":"Gentile","year":"2009","journal-title":"Euro Surveill."},{"key":"ref_51","first-page":"159","article-title":"Spread of hepatitis A: Recent studies on virus survival, transfer and inactivation","volume":"11","author":"Sattar","year":"2000","journal-title":"Can. J. Infect. Dis."},{"key":"ref_52","first-page":"230","article-title":"A family cluster of hepatitis A virus due to an uncommon IA strain circulating in Campania (southern Italy), not associated with raw shellfish or berries: A wake-up call to implement vaccination against hepatitis A?","volume":"3","author":"Tosoni","year":"2016","journal-title":"Infez. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/14760584.2019.1580578","article-title":"Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric","volume":"18","author":"Bravo","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jmv.25197","article-title":"Hepatitis A vaccine immune response 22 years after vaccination","volume":"90","author":"Mosites","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"International Consensus Group on Hepatitis A Virus Immunity. Hepatitis A booster vaccination: Is there a need?","volume":"362","author":"Banatvala","year":"2003","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0022172400055133","article-title":"The response to oral poliovaccine in persons aged 16\u201318 years","volume":"76","author":"Smith","year":"1976","journal-title":"J. Hyg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00054-12","article-title":"Seroepidemiology of polioviruses among university students in northern Italy","volume":"19","author":"Baldo","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/139.2.225","article-title":"Seroimmunity to polioviruses in U.S. Army recruits","volume":"139","author":"Burke","year":"1979","journal-title":"J. Infect. Dis."},{"key":"ref_59","first-page":"275","article-title":"Seroimmunity to polioviruses in an urban population of Italy","volume":"54","author":"Volpi","year":"1976","journal-title":"Bull. World Health Organ."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: Past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: A community-based, randomized controlled trial","volume":"12","author":"Jafari","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: An open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"key":"ref_65","first-page":"145","article-title":"Polio vaccines: WHO position paper, March 2016","volume":"91","year":"2016","journal-title":"Wkly. Epidemiol. Rec."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Lewnard, J.A., and Cobey, S. (2018). Immune History and Influenza Vaccine Effectiveness. Vaccines, 6.","DOI":"10.3390\/vaccines6020028"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","article-title":"Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: Safety and immunogenicity","volume":"134","author":"Salemi","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/cei.12292","article-title":"Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals","volume":"177","author":"Milanetti","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_70","first-page":"547","article-title":"Characterization of influenza outbreaks in Lebanon during the 2013\/14 and 2014\/15 seasons","volume":"22","author":"Saito","year":"2016","journal-title":"East Mediterr. Health J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2018.07.010","article-title":"Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy","volume":"195","author":"Caporuscio","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2776(08)60465-4","article-title":"Regulatory effect of antibody on the immune response","volume":"8","author":"Uhr","year":"1968","journal-title":"Adv. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.vaccine.2020.01.045","article-title":"Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies","volume":"38","author":"Bovay","year":"2020","journal-title":"Vaccine"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/87\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:12:12Z","timestamp":1760159532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,17]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["biomedicines9010087"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9010087","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2021,1,17]]}}}